Lantas-DX 30 Capsule MR
Marketer
Qantas Biopharma Private Limited
Salt Composition
Dexlansoprazole (30mg)
Overview Lantas-DX 30 Capsule MR
Acid reducer medication, Lantas-DX 30 MR Capsules, diminishes gastric acid secretion. It's indicated for managing stomach and intestinal conditions stemming from excess acid, such as heartburn and acid reflux. Dosage, as determined by your physician, should be the minimum effective dose for the shortest duration. Administration is intravenous, performed by a medical professional. Therapeutic effects may take several weeks; your doctor will specify treatment length. Continue taking it as prescribed, even with rapid symptom improvement. Long-term use may necessitate regular magnesium level monitoring due to potential depletion. Common, typically mild, side effects include nausea, vomiting, abdominal discomfort, diarrhea, and malaise; consult your doctor if persistent or bothersome. Prolonged use increases the risk of side effects. While rare, some serious adverse reactions require immediate medical attention—discuss these with your physician. Extended use might increase fracture risk. Minimize consumption of trigger foods like rich, spicy, or fatty meals, caffeinated beverages (tea, coffee, cola), and alcohol. Lantas-DX 30 MR Capsules are unsuitable for individuals with severe hepatic impairment, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. While alcohol doesn't directly affect the drug's mechanism, it increases gastric acid production. Dizziness, drowsiness, or visual disturbances may occur; avoid operating machinery or vehicles if affected. Use during pregnancy and breastfeeding is generally discouraged.
Primary Ingredients of Lantas-DX 30 Capsule MR
No text provided. Please provide the text you would like me to rephrase.
Uses of Lantas-DX 30 Capsule MR
Acid indigestion and gastroesophageal reflux
Major Benefits of Lantas-DX 30 Capsule MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lantas-DX 30 MR Capsules. Ingest the capsules whole; avoid chewing, crushing, or breaking them. Administer on an empty stomach.
Common Side effects of Lantas-DX 30 Capsule MR:
- Nausea
- Abdominal pain
- Flatulence
- Diarrhea
- Vomiting
How to use Lantas-DX 30 Capsule MR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule without chewing, crushing, or fracturing it. Lantas-DX 30 MR Capsules should be administered on an empty stomach.
How Lantas-DX 30 Capsule MR works:
Lantas-DX 30 MR capsules contain a proton pump inhibitor that diminishes stomach acid production, thereby alleviating symptoms of acid indigestion and heartburn.
SAFETY ADVICE
AlcoholUNSAFE
Combining Lantas-DX 30 Capsule MR and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Data on Lantas-DX 30 Capsule MR use in pregnancy is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Lantas-DX 30 Capsule MR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Lantas-DX 30 Capsule MR's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lantas-DX 30 MR capsules can be used safely by individuals with kidney impairment. No alteration of the Lantas-DX 30 MR capsule dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Lantas-DX 30 MR capsules. Dosage modification of Lantas-DX 30 MR capsules may be necessary. Physician consultation is recommended.
What if you forget to take Lantas-DX 30 Capsule MR :
Should you forget a Lantas-DX 30 Capsule MR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Lantas-DX 30 Capsule MR
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |


